Is immunotherapy the holy grail for pancreatic cancer?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is immunotherapy the holy grail for pancreatic cancer?

Published:2019-12 Issue:17 Volume:11 Page:1435-1438
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Andersson Roland¹,Pereira Carlos-Filipe²³,Bauden Monika¹,Ansari Daniel¹

Affiliation:

1. Department of Surgery, Clinical Sciences Lund, Lund University & Skåne University Hospital, Lund, Sweden

2. Molecular Medicine & Gene Therapy, Lund Stem Cell Center, Lund University, BMC A12, 221 84, Lund, Sweden

3. Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt-2019-0164

Reference31 articles.

1. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

2. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

3. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

4. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

5. Pancreatic cancer: yesterday, today and tomorrow

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic Cancer using Nanotechnology;Current Cancer Drug Targets;2023-10

2. Pyruvate Kinase Activity Regulates Cystine Starvation Induced Ferroptosis through Malic Enzyme 1 in Pancreatic Cancer Cells;2023-09-17

3. Pd-L1 Blockade Followed by Irreversible Electroporation of a Liver Metastasis in Pancreatic Cancer Patients;2023

4. The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer;Cancer Research Communications;2022-07-27

5. Pancreatic cancer – the past, the present, and the future;Scandinavian Journal of Gastroenterology;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3